News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,420 Results
Type
Article (14011)
Company Profile (103)
Press Release (256306)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88805)
Career Advice (499)
Deals (15482)
Drug Delivery (67)
Drug Development (37498)
Employer Resources (52)
FDA (6436)
Job Trends (6374)
News (152153)
Policy (14185)
Tag
Academia (457)
Accelerated approval (2)
Adcomms (6)
Allergies (40)
Alliances (23403)
ALS (37)
Alzheimer's disease (416)
Antibody-drug conjugate (ADC) (45)
Approvals (6485)
Artificial intelligence (114)
Autoimmune disease (10)
Automation (4)
Bankruptcy (149)
Best Places to Work (4525)
BIOSECURE Act (9)
Biosimilars (58)
Biotechnology (40)
Bladder cancer (23)
Brain cancer (16)
Breast cancer (90)
Cancer (721)
Cardiovascular disease (75)
Career advice (435)
Career pathing (24)
CAR-T (39)
Cell therapy (110)
Cervical cancer (5)
Clinical research (31714)
Collaboration (363)
Compensation (167)
Complete response letters (17)
COVID-19 (771)
CRISPR (23)
C-suite (131)
Cystic fibrosis (40)
Data (747)
Decentralized trials (1)
Denatured (15)
Depression (10)
Diabetes (85)
Diagnostics (1386)
Diversity (3)
Diversity, equity & inclusion (15)
Drug discovery (61)
Drug pricing (66)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32616)
Editorial (14)
Employer branding (4)
Employer resources (47)
Events (38711)
Executive appointments (404)
FDA (6909)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (220)
Gene editing (41)
Generative AI (9)
Gene therapy (105)
GLP-1 (358)
Government (1330)
Grass and pollen (3)
Guidances (27)
Healthcare (3680)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (806)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (49)
Interviews (64)
IPO (5978)
IRA (29)
Job creations (2064)
Job search strategy (386)
Kidney cancer (7)
Labor market (26)
Layoffs (194)
Leadership (7)
Legal (3451)
Liver cancer (21)
Lung cancer (105)
Lymphoma (75)
Machine learning (2)
Management (19)
Manufacturing (165)
MASH (34)
Medical device (1377)
Medtech (1379)
Mergers & acquisitions (9723)
Metabolic disorders (272)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (28)
Neuropsychiatric disorders (8)
Neuroscience (614)
NextGen: Class of 2025 (1640)
Non-profit (622)
Now hiring (18)
Obesity (155)
Opinion (120)
Ovarian cancer (22)
Pain (56)
Pancreatic cancer (15)
Parkinson's disease (54)
Partnered (7)
Patents (125)
Patient recruitment (30)
Peanut (13)
People (29150)
Pharmaceutical (65)
Pharmacy benefit managers (11)
Phase I (8306)
Phase II (13429)
Phase III (12003)
Pipeline (497)
Policy (73)
Postmarket research (1423)
Preclinical (3340)
Press Release (26)
Prostate cancer (51)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (174)
Real estate (2656)
Recruiting (18)
Regulatory (10276)
Reports (18)
Research institute (580)
Resumes & cover letters (58)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (38)
Series B (15)
Service/supplier (4)
Sickle cell disease (32)
Special edition (8)
Spinal muscular atrophy (80)
Sponsored (6)
Startups (1637)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (32)
The Weekly (30)
Vaccines (168)
Venture capitalists (15)
Weight loss (101)
Women's health (9)
Worklife (9)
Date
Today (72)
Last 7 days (303)
Last 30 days (957)
Last 365 days (12243)
2025 (4169)
2024 (12957)
2023 (14684)
2022 (20013)
2021 (20459)
2020 (19407)
2019 (15161)
2018 (11940)
2017 (14132)
2016 (13338)
2015 (15736)
2014 (12563)
2013 (10669)
2012 (11475)
2011 (12009)
2010 (10961)
Location
Africa (316)
Alabama (13)
Alaska (1)
Arizona (58)
Arkansas (3)
Asia (20349)
Australia (2648)
California (1928)
Canada (964)
China (265)
Colorado (75)
Connecticut (74)
Delaware (69)
Europe (39968)
Florida (347)
Georgia (42)
Idaho (11)
Illinois (213)
India (16)
Indiana (140)
Iowa (1)
Japan (101)
Kansas (58)
Kentucky (13)
Louisiana (1)
Maine (2)
Maryland (278)
Massachusetts (1611)
Michigan (31)
Minnesota (99)
Missouri (26)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (827)
New Mexico (7)
New York (558)
North Carolina (408)
North Dakota (2)
Northern California (810)
Ohio (52)
Oklahoma (4)
Oregon (17)
Pennsylvania (474)
Puerto Rico (8)
Rhode Island (10)
South America (505)
South Carolina (2)
Southern California (800)
Tennessee (35)
Texas (243)
United States (7839)
Utah (37)
Virginia (80)
Washington D.C. (33)
Washington State (130)
Wisconsin (17)
270,420 Results for "lb pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LB Pharmaceuticals Presents New Data from Phase 2 Clinical Trial of LB-102 at the 2025 Annual Congress of the Schizophrenia International Research Society
April 1, 2025
·
5 min read
Press Releases
LB Pharmaceuticals Announces Key Executive Appointments to Support Growth and Late-Stage Development of LB-102
February 11, 2025
·
4 min read
Press Releases
LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia
January 9, 2025
·
5 min read
Press Releases
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
March 28, 2025
·
5 min read
Press Releases
LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Mogan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
UPDATE – LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Press Releases
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
April 1, 2025
·
4 min read
Press Releases
New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form
March 11, 2025
·
4 min read
Press Releases
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment
November 19, 2024
·
4 min read
Press Releases
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
January 22, 2025
·
3 min read
1 of 27,042
Next
